EN DE
Watch Inversora Juramento SA for free: we tell you when fair value or trend changes.
Data-driven stock valuation

Inversora Juramento SA (INVJ) fair value: what the stock is really worth

As of Nov 6, 2026: fair value (intrinsic value) of Inversora Juramento SA stock ARS 239, price ARS 353, that is 32.3% below the price, quality 42 out of 100. Rating: overvalued. Calculated from audited financials with 6 of our 26 valuation models and 37 quality factors, updated daily.

  1. Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free

Consumer Defensive AR · ISIN ARINJU010010

IJ Inversora Juramento SA logo Thin data Nov 4, 2026

Inversora Juramento SA

INVJ · BA
Expensive, weak quality

Our calculation puts a fair price 32% below what the stock costs today.

Low debt
Revenue last quarter +25% vs. a year ago.
Quality 42/100
Mixed Growth (revenue 5y +95.9 %/yr in ARS)
Thin margins · 4.5% net margin (TTM)
Fair value 239.08 ARS · Overvalued
Negative free cash flow
Trails peers (4/11)
Narrow moat 26/100
Thin data
⟳ Cyclical
Watch Inversora Juramento SA for free: we tell you when fair value or trend changes. Watch for free

What runs behind every stock

26 valuation models 8 families, DCF to NCAV 37 quality factors margins, balance sheet, cashflow, debt 6 AI factors moat, what no ratio measures 2,000+ data points verified, per stock, median

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

711.00 ARS 18.00 ARS Fair Value 239.08 ARS Jul 2021 Nov 2026

White line = price, green steps = our fair value per fiscal year. As of Nov 4, 2026.

How to read this chart

60‑month range 18.00 ARS – 711.00 ARS · fair‑value band 224.68 ARS – 249.80 ARS · the 353.00 ARS price screens above the 239.08 ARS fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 4, 2026.

Follow Inversora Juramento in your weekly email

Every Wednesday you see whether Inversora Juramento is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Inversora Juramento S.A. operates as an agricultural and livestock company in the northwestern region of Argentina. The company engages in the production, industrialization, marketing, and sale of meat and agricultural products.

Show moreShow less

Its agricultural products include soybeans, sorghum, alfalfa, pastures, and corn. The company has approximately 89,504 hectares of land located in the province of Salta. It also exports its products. The company was founded in 1990 and is based in Salta, Argentina.

Stock analysis

Inversora Juramento SA (INVJ) currently trades at 353.00 ARS, while our model-based Fair Value estimate is 239.08 ARS, 32% below the price, so the stock looks overvalued today.

Show more

Valuation

Bull case: the Multiples group reads highest at a median of 396.02 ARS per share, and 2 of the 6 models we run sit above the 353.00 ARS price.

Bear case: the Asset-Based group reads lowest at 105.98 ARS, and 4 of the 6 models stay below the price. Data coverage for this calculation is low.

Scenario range: 224.68 ARS (bear) to 249.80 ARS (bull), the price of 353.00 ARS sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 42/100 (below-average quality), in the Consumer Defensive sector.

Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.

Inversora Juramento SA reported revenue of 84.3B ARS in FY2023 versus 5.7B ARS in FY2019, a compound +96.3%/yr. Reported net income was −2.3B ARS in FY2023.

Key figures

Market cap 299B ARS (≈ $194M) Micro · P/S ratio 0.73 · EPS (TTM) −6.85 ARS · Net margin −2.8% · Return on equity 4.2% · Return on assets (EBIT) 6.2% (5-year average) · Operating margin −26.8% · Revenue growth (YoY) +24.5%.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 26 out of 100 (medium confidence).

What moves the price

The share trades about 50% below its 52-week high and 5% above its 52-week low, currently below its 200-day average.

For context, the median of 10 Consumer Defensive peers we cover trades at 10% fair-value upside, at −32%, INVJ screens richer than that median.

Fair Value models

Bear 224.68 ARS Fair Value 239.08 ARS Bull 249.80 ARS
Price 353.00 ARS · Downside -32.3%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds. Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Best data coverage
EPV 112.34 ARS 119.54 ARS 124.90 ARS 74
ROIC Compounder 112.34 ARS 119.54 ARS 124.90 ARS 70
EV/EBITDA 293.74 ARS 396.02 ARS 498.30 ARS 67
All 6 models by family
Earnings-Based
EPV 112.34 ARS 119.54 ARS 124.90 ARS 74
Multiples
EV/EBIT 344.68 ARS 463.94 ARS 583.20 ARS 66
EV/EBITDA 293.74 ARS 396.02 ARS 498.30 ARS 67
EV/Revenue 131.21 ARS 193.06 ARS 254.91 ARS 53
Asset-Based
NCAV (Graham) 79.09 ARS 105.98 ARS 158.17 ARS 54
Economic Profit
ROIC Compounder 112.34 ARS 119.54 ARS 124.90 ARS 70

The fair value above starts from this blend and is adjusted for a cyclical trough year.

Open the full fair value analysis →

Quality Score breakdown

Overall quality 42/100

It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.

Profitability 17
How much profit the company makes from its sales and capital
Quality Growth 80
Are margins and returns getting better?
Cashflow 6
Do the profits arrive as real cash?
Financial strength 78
Debt, balance sheet and risk of trouble
Investment 30
Does it invest with discipline instead of growing at any price?
Low Volatility 62
How calm the share price moves, does not count
Price momentum 19
Price momentum of the last 3 to 12 months, does not count
Near the 52-week high 2
Distance to the 52-week high, does not count
New shares 56
Buys back shares or issues new ones?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 50/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Revenue growth 1 year
+170.3%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+119.8%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+95.9%
Revenue growth 8 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+74.0%
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
12.6% (2017) → 20.4% (2023)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2023 is a loss year, no rate is defined from a loss
not computed

INVJ screens overvalued: fair value 32% below the price. Compare with Muyuan Foods Group →

Compare Inversora Juramento SA with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Farm Products · 291 stocks

Beats the industry median on 3/10 measures
Overall it trails its industry peers.
Valuation
Quality Score 42 · Below median
Fair Value upside −32.3% · Below median
Profitability
Return on equity (12 months) 4.2% · Below median
Return on assets −1.4% · Bottom 25%
Net margin (12 months) 4.5% · Above median
Operating margin (12 months) −26.8% · Bottom 25%
Growth and dividend
Revenue growth (quarter YoY) 24.5% · Top 25%

Valuation Multiplesvs Farm Products median · lower = cheaper

P/B 3.08× · Priciest 25%
P/S (12 months) 0.73× · Cheaper than median
EV/EBITDA 45.8× · Priciest 25%

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)0 · sector 27
FUTURE (revenue growth)100 · sector 15
PAST (return on equity)17 · sector 17
HEALTH (low debt)100 · sector 94
DIVIDEND (yield)0 · sector 41

VALUE 0: the price sits above our fair-value range.

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Farm Products stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value Compare
Charoen Pokphand Foods Public Company CPF 20.10 THB 40.78 THB +103% vs INVJ
Mowi ASA MOWI kr 218.00 kr 273.41 +25% vs INVJ
Tyson Foods, Inc TSN $59.68 $73.24 +23% vs INVJ
Muyuan Foods Group 002714 ¥44.40 ¥53.02 +19% vs INVJ
United Plantations Berhad 2089 30.38 MYR 33.42 MYR +10% vs INVJ
Archer-Daniels-Midland Company ADM $69.97 $61.55 −12% vs INVJ
Wens Foodstuff Group 300498 ¥16.82 ¥12.08 −28% vs INVJ
Fujian Wanchen Food Group 300972 ¥129.60 ¥88.62 −32% vs INVJ
Bunge Global SA BG $99.10 $56.81 −43% vs INVJ
SalMar ASA SALM kr 572.50 kr 260.28 −55% vs INVJ

Explore undervalued stocks

More undervalued Consumer Defensive stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued High-Quality StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend StocksUndervalued 52-Week Low Stocks

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

Stock screenerFilter by region, size and sector Compare toolTwo stocks side by side Extrinsic Value Calculator…Free calculator Peter Lynch Fair Value Formula &…Free calculator
Run the numbers yourself: free valuation calculators
DCF CalculatorP/E Ratio CalculatorPEG Ratio CalculatorGraham NumberPeter Lynch FormulaDDM CalculatorIntrinsic ValueIntrinsic vs Extrinsic ValueP/E Ratio by Sector
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Inversora Juramento SA: fair value per Fair Value Calculator

Cite: Fair Value Calculator (2026). "Inversora Juramento SA Fair Value". https://www.fairvalue-calculator.com/stock/INVJ

Frequently asked questions

Is Inversora Juramento SA (INVJ) overvalued or undervalued?
As of Nov 4, 2026, our model estimates a fair value of 239.08 ARS versus a price of 353.00 ARS, about 32% lower (overvalued).
What is the fair value of INVJ?
Our model-based fair value for Inversora Juramento SA is 239.08 ARS (as of Nov 4, 2026), built from audited fundamentals. The current price: 353.00 ARS.
What is the quality score of INVJ?
Inversora Juramento SA has a Quality Score of 42/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Inversora Juramento SA (INVJ)?
Our model-based price target is the fair value of 239.08 ARS (as of Nov 4, 2026) from 6 valuation models. Cautious scenario 224.68 ARS, optimistic scenario 249.80 ARS. It is a calculation from audited fundamentals, not an analyst target.
What is the Inversora Juramento SA stock forecast for 2026?
Our models put fair value at 239.08 ARS, about 32% lower versus a price of 353.00 ARS (overvalued). Cautious scenario 224.68 ARS, optimistic scenario 249.80 ARS. The calculation is refreshed regularly with new filings.
What is the intrinsic value of Inversora Juramento SA (INVJ)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Inversora Juramento SA it is 239.08 ARS per share (as of Nov 4, 2026), against a price of 353.00 ARS. It is the blended result of 6 valuation models in 4 families (Earnings-Based, Multiples, Asset-Based, Economic Profit).
Is Inversora Juramento SA stock overvalued or undervalued in 2026?
As of Nov 4, 2026, INVJ trades above its calculated fair value: price 353.00 ARS, fair value 239.08 ARS, a gap of about −32% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of INVJ?
No. The price is what the market pays today (353.00 ARS); the fair value is what the company's own numbers justify (239.08 ARS). For Inversora Juramento SA the two are 113.92 ARS per share apart. That gap is exactly why we show both numbers side by side.
How much is Inversora Juramento SA worth?
The market values Inversora Juramento SA at about 299B ARS (market capitalisation, as of Nov 4, 2026). Per share that is 353.00 ARS; our models calculate a fair value of 239.08 ARS per share.
What do the bullish and bearish scenarios say about INVJ?
Our models span a range for Inversora Juramento SA: cautious scenario 224.68 ARS, base 239.08 ARS, optimistic 249.80 ARS per share (as of Nov 4, 2026, price 353.00 ARS). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of Inversora Juramento SA (INVJ)?
Balance-sheet figures for Inversora Juramento SA (as of Nov 4, 2026): return on equity 4.2%. They feed the Quality Score of 42/100, which measures business quality independently of the share price.
How far is INVJ from its 52-week high?
Inversora Juramento SA trades at 353.00 ARS, about 50% below its 52-week high of 711.00 ARS and 5% above the low of 335.00 ARS (as of Nov 6, 2026). Distance from the high says nothing about value: that is what the fair value of 239.08 ARS is for.
Which stocks are comparable to Inversora Juramento SA?
From the same area (Consumer Defensive) we also value Muyuan Foods Group, Archer-Daniels-Midland Company, Tyson Foods, Inc, Bunge Global SA, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Inversora Juramento SA stock attractive at the current price?
The data as of Nov 4, 2026: price 353.00 ARS, calculated fair value 239.08 ARS (−32%), Quality Score 42/100, from 6 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of INVJ calculated?
We run Inversora Juramento SA through 6 models from 4 families: Earnings-Based, Multiples, Asset-Based, Economic Profit. Every model gets the same audited fundamentals; the fair value of 239.08 ARS builds on their evidence-weighted average, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.3% above its aggregate fair value. Inversora Juramento SA itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Inversora Juramento SA (INVJ)?
The closing price on Nov 6, 2026 was 353.00 ARS. Our model-based fair value is 239.08 ARS, about 32% lower (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Inversora Juramento SA right now?
The price sits above even our optimistic bull case (249.80 ARS). The favourable scenario is already priced in. Weak quality (42/100) and above fair value at the same time, the margin of safety is missing on both counts. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution. The models converge in a tight band (224.68 ARS to 249.80 ARS), unusually little disagreement for a valuation.

Key figures of Inversora Juramento SA

How large is the market capitalisation of Inversora Juramento SA (INVJ)?
The market capitalisation of Inversora Juramento SA is 299B ARS (≈ $194M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Inversora Juramento SA (INVJ)?
The price-to-sales ratio of Inversora Juramento SA is 0.73 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Inversora Juramento SA (INVJ)?
Earnings per share at Inversora Juramento SA are −6.85 ARS. Earnings per share over the last twelve months: total profit spread across every single share.
What is the net margin of Inversora Juramento SA (INVJ)?
The net margin of Inversora Juramento SA is −2.8% (fiscal year 2023). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Inversora Juramento SA (INVJ)?
The return on equity (ROE) of Inversora Juramento SA is 4.2% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Inversora Juramento SA (INVJ)?
On an EBIT basis the return on assets of Inversora Juramento SA is 6.2% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Inversora Juramento SA (INVJ)?
The operating margin of Inversora Juramento SA is −26.8% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Inversora Juramento SA (INVJ)?
Revenue at Inversora Juramento SA is growing +24.5% versus a year earlier (3y avg +120%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Inversora Juramento SA (INVJ)?
Earnings per share at Inversora Juramento SA are growing +722% versus a year earlier. How much earnings per share grew versus a year earlier.
How much free cash flow does Inversora Juramento SA (INVJ) generate?
The free cash flow of Inversora Juramento SA is −3.3B ARS (fiscal year 2023). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net debt does Inversora Juramento SA (INVJ) carry?
The net debt of Inversora Juramento SA is 8.0B ARS (fiscal year 2023). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed

Watch Inversora Juramento SA in the live analysis

One click puts Inversora Juramento SA on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.